Michelle Berrey
2021
Compensation breakdown
| Non-Equity Incentive Plan | $148,970 |
|---|---|
| Option Awards | $1,186,680 |
| Salary | $329,545 |
| Stock Awards | $1,434,983 |
| Other | $18,321 |
| Total | $3,118,499 |
Berrey received $1.4M in stock awards, accounting for 46% of the total pay in 2021.
Berrey also received $149K in non-equity incentive plan, $1.2M in option awards, $329.5K in salary and $18.3K in other compensation.
Rankings
In 2021, Michelle Berrey's compensation ranked 4,282nd out of 12,406 executives tracked by ExecPay. In other words, Berrey earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,282 out of 12,406 | 66th |
Division Manufacturing | 1,765 out of 5,492 | 68th |
Major group Chemicals And Allied Products | 738 out of 2,368 | 69th |
Industry group Drugs | 659 out of 2,089 | 69th |
Industry Pharmaceutical Preparations | 466 out of 1,536 | 70th |
Pay ratio
| Michelle Berrey's Pay | $3,118,499 |
|---|---|
| Median Employee's Pay | $216,748 |
| Pay Ratio | 14to 1 |
In 2021, the annual total compensation of Michelle Berrey was $3,118,499.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $216,748.
The ratio of Michelle Berrey's pay to the pay of median employee was therefore 14 to one.
Berrey's colleagues
We found six more compensation records of executives who worked with Michelle Berrey at Intercept Pharmaceuticals in 2021.
2021
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
2021
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
2021
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
2021
Andrew Saik
Intercept Pharmaceuticals
Chief Financial Officer
2021
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2021
Rocco Venezia
Intercept Pharmaceuticals